QCOM vs SYRE · P/E 16, rev $44.28B vs $7.60B cap
Qualcomm Incorporated (QCOM) versus Spyre Therapeutics Inc. (SYRE) — a side-by-side from cached financials, not a winner call.
Qualcomm Incorporated (QCOM) is a semiconductors company listed on US. It is led by Cristiano Amon.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Latest reported QCOM revenue for 2025-09-28 was $44.28B. Net income was $5.54B. QCOM currently screens at market cap $175.02B and trailing P/E 16.3.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
QCOM currently screens at market cap $175.02B and trailing P/E 16.3. SYRE currently screens at market cap $7.60B.
Not investment advice. Open the QCOM and SYRE stock pages for the full models.
Not investment advice.